华森制药(002907.SZ)收到药品再注册批准通知书

Core Viewpoint - Huason Pharmaceutical (002907.SZ) has received approval from the Chongqing Municipal Drug Administration for the re-registration of two pharmaceutical products: Glycyrrhizic Acid Ammonium and Sodium Ferulate Injection [1] Group 1: Product Approvals - The company has been granted a "Chemical Raw Material Drug Re-registration Approval Notice" for Glycyrrhizic Acid Ammonium, which is a raw material used for producing Glycyrrhizic Acid Ammonium Injection [1] - Additionally, the company received a "Drug Re-registration Approval Notice" for Sodium Ferulate Injection, which is used as an auxiliary treatment for ischemic cardiovascular and cerebrovascular diseases [1]